Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Response fluctuations in Parkinson's disease.

R A Roos1, C B Vredevoogd, E A van der Velde

  • 1Department of Neurology, Academic Hospital Leiden, The Netherlands.

Neurology
|September 1, 1990
PubMed
Summary

Response fluctuations in Parkinson's disease are not linked to individual factors. Early levodopa treatment is not discouraged, but dosage increases may indicate future fluctuations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease.

Psychological medicine·2020
Same author

An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).

BJOG : an international journal of obstetrics and gynaecology·2016
Same author

Recommendations for the predictive genetic test in Huntington's disease.

Clinical genetics·2012
Same author

Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway.

Neurobiology of disease·2012
Same author

Enhanced Abeta40 deposition was associated with increased Abeta42-43 in cerebral vasculature with Dutch-type hereditary cerebral hemorrhage with amyloidosis (HCHWA-D).

Annals of the New York Academy of Sciences·2002
Same author

Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records.

Pharmacoepidemiology and drug safety·2002

Area of Science:

  • Neurology
  • Neuroscience
  • Movement Disorders

Background:

  • Parkinson's disease (PD) is a progressive neurodegenerative disorder.
  • Levodopa is a primary treatment for PD symptoms.
  • Response fluctuations, such as wearing-off and dyskinesia, are common challenges in PD management.

Purpose of the Study:

  • To investigate factors influencing the occurrence of response fluctuations in Parkinson's disease patients.
  • To examine the impact of treatment timing and dosage adjustments on motor fluctuations.

Main Methods:

  • A cohort of 91 Parkinson's disease patients was studied.
  • Time-independent covariates included age at onset, symptom presentation, illness duration, and disease stage at levodopa initiation.
  • Time-dependent covariates included mean and last levodopa dosage.

Main Results:

  • No single factor independently predicted response fluctuations.
  • A tendency for fewer fluctuations was observed in patients aged 60+ who started levodopa >2 years after symptom onset.
  • Increased levodopa dosage, reflecting disease progression, was associated with a higher likelihood of fluctuations.

Conclusions:

  • There is no evidence to support delaying levodopa treatment in Parkinson's disease.
  • Response fluctuations are likely in patients requiring recent levodopa dosage increases.
  • Combined analysis suggests a potential protective effect of later levodopa initiation in older patients.

Related Experiment Videos